Author:Sonictec · Updated
A sponsor is an Australian party with ongoing obligations
A medical device sponsor must meet Australian eligibility requirements, generally as an Australian resident individual or a body corporate carrying on business in Australia, and has obligations arising from the actual import, supply and application arrangements. An overseas manufacturer cannot establish sponsorship merely by finding a mailing address. Confirm eligibility, the business relationship and TGA client-account arrangements before applying.
The sponsor has direct responsibilities in the ARTG application and Australian post-market management, without replacing the manufacturer’s responsibilities for design, production and conformity assessment. Both parties need workable access to information, issue-handling and change-notification arrangements. A certificate-holding agreement and annual fee alone are inadequate when TGA requests, complaints or recalls arise.
Source:TGA: The role of the sponsor ；TGA: Post-market responsibilities for medical devices
Work required during registration
The manufacturer supplies the intended purpose, technical characteristics and evidence. The sponsor checks Australian classification, application scope and the evidence pathway, then completes the applicable ME and ARTG submissions through TBS. Statements made in the application must be supported, with consistent manufacturer evidence, declarations, labels, clinical and quality-system documents.
Not every application requires the complete technical file to be uploaded initially, but the sponsor must be able to supply the required information. On receiving a TGA Request for Information, confirm the device and document versions, obtain and review the manufacturer’s response and submit it within the deadline. Document readiness and successful system submission are separate checkpoints.
Source:TGA: Evidence requirements for medical device market authorisation ；TGA: Manufacturer evidence
Sponsorship and distribution may be separate roles
Sales, storage and logistics duties differ from a sponsor’s regulatory responsibilities. One company may perform both roles, or the roles may be separated. Combining them can reduce coordination, but terminating distribution may also require changes to sponsorship. An independent sponsor can reduce dependence on a single channel, while still needing distributors’ batch destinations, complaints and recall execution information.
Neither model guarantees uninterrupted supply merely through the contract title. Review access to technical information, ARTG transfer conditions, stock and labelling, costs and exit cooperation. A distributor’s own supply and advertising obligations do not disappear because a separate sponsor is appointed.
Source:TGA: The role of the sponsor ；TGA: Post-market responsibilities for medical devices
Information the manufacturer must continue to provide
Information arrangements should cover both pre-application and post-market stages. Document the required files, version control, contacts, emergency cover and notification deadlines in a technical agreement. Design, intended-purpose, site, certificate or labelling changes should not wait until renewal: assess their effect on Australian inclusion, evidence or supply conditions first.
| Stage | Information to share |
|---|---|
| Application preparation | Device and model lists, design and risk files, verification reports, overseas certificates and annexes, QMS evidence, clinical evaluation, labels, instructions and change history. |
| Post-market maintenance | Global complaints and safety information, corrective actions, product and site changes, certificate renewals or suspensions, and applicable periodic safety reports and information required by Australian entry conditions. |
Source:TGA: Post-market responsibilities for medical devices
Adverse events: report on time while the investigation continues
Sponsors need complaint intake, severity assessment and escalation procedures, rather than waiting for the manufacturer’s root-cause investigation before considering reporting. Reportable adverse and near-adverse events are generally submitted through Medical Device Incident Reporting (MDIR) in TBS to TGA’s IRIS scheme. Initial deadlines below run from the sponsor becoming aware; day-based deadlines are calendar days.
After the initial report, provide follow-up reports at least every 30 calendar days and a final report within 120 calendar days of the initial submission. Where information is incomplete, submit what is available and add further information. Reporting does not itself admit liability. Document any reporting-exemption assessment rather than automatically withholding reports while causation is uncertain.
These TGA event-reporting requirements concern events occurring in Australia. Overseas events generally do not require individual TGA reports, but records should be available on request. Overseas remedial action involving a device also supplied in Australia must be reported to the TGA recalls team. This distinction does not mean overseas safety information can be ignored.
| Event type | Deadline after awareness |
|---|---|
| Serious threat to public health | Within 48 hours |
| Death or serious deterioration in health | Within 10 days |
| Could cause death or serious deterioration, including if repeated | Within 30 days |
Source:TGA: Reporting medical device adverse events
Recalls depend on traceable batches and recipients
When a recall, product alert or correction may be needed, the sponsor should contact the TGA recalls team under PRAC with the issue, risk, affected models and batches, distribution scope and proposed action. The manufacturer investigates and develops corrective measures; the sponsor coordinates Australian regulatory communication and implementation; distributors and warehouses provide destinations and carry out notification, quarantine or recovery.
Preparation should precede an incident. A batch should be traceable to quantities, dates, recipients and contact details, with confirmation of notification and recovery or correction. Sales totals or orders that cannot be linked to models and batches are inadequate. Confirm implementation and reporting milestones for the particular action with TGA.
Source:TGA: Recalls, product alerts and product corrections ；TGA: Distribution records and retention periods
Distribution records do not all have a five-year minimum
TGA requires sponsors to retain distribution records to identify the manufacturer of each batch and expedite recalls. Records should cover supply destinations, including relevant users, distribution centres, hospitals and export countries. The table gives minimum distribution-record retention periods, not a universal destruction schedule for clinical, quality or legal files; other applicable requirements need separate review.
| Class | Minimum period |
|---|---|
| MD Class III, implantable MD Class IIb, IVD Class 4 | 10 years |
| Other device classifications | 5 years |
Source:TGA: Distribution records and retention periods
Maintain annual charges, advertising and entry conditions
Track applicable annual charges, certificate status, TBS contacts and ARTG conditions. Some entries carry additional reporting or other conditions; schedule work against the particular entry rather than assuming one product’s annual reporting duty applies to every device. Include UDI, labelling and change control in routine maintenance after inclusion.
Use the current TGA schedule for official charges and the engagement agreement for sponsor-service fees. Check promotional claims against advertising rules and the device’s intended purpose; ARTG inclusion does not justify advertising it as “TGA approved”. Regulatory responses may include corrective requirements, suspension or cancellation, infringement notices, and civil or criminal action. The response depends on the breach and applicable law, not a fixed sequence of escalating steps.
Source:TGA: Post-market responsibilities for medical devices ；TGA: Do not use “TGA approved” in advertising ；TGA: current application fees and annual charges
Changing sponsor: check transfer eligibility and handover first
A change of sponsor has statutory conditions and notification procedures; it is not an unrestricted change of the company name on a certificate. Following a qualifying transfer, the new sponsor must notify TGA within three months of the event and provide the required evidence of transfer or assignment. Manufacturer evidence may also be needed for devices. If the arrangement does not qualify, establish whether a new ARTG application is required.
Agree in advance who assists the transfer, when technical and distribution records are handed over, how open complaints are handled, and how stock labelling, fees and ongoing supply will be managed. The new sponsor should promptly check entry conditions and ongoing duties; the three-month notification period is not a grace period without responsibility.
Source:TGA: changing the Sponsor of a therapeutic good
Specify the engagement when choosing a sponsor
Alongside the quote, ask about experience with similar devices, who responds to TGA, emergency contact availability and secure technical-file sharing. Discuss changes, complaints, recalls and exit arrangements as well as initial submission fees.
Sonictec can discuss registration, sponsorship and post-market cooperation based on device type, certificates, ARTG status and Australian supply arrangements. For an initial discussion, identify the manufacturer, proposed devices, current sponsor and whether the task is a new application, ongoing maintenance or a change of partner.
- Application responsibilities and deliverables: who prepares, reviews and submits, and which tasks cost extra.
- Safety and change notifications: contacts, deadlines, emergency escalation and recordkeeping.
- Ongoing maintenance: certificates, annual charges, entry conditions, UDI, complaints and recall cooperation.
- Exit arrangements: technical and distribution records, transfer cooperation, open matters, confidentiality and dispute handling.
Source:TGA: Post-market responsibilities for medical devices
Further reading
- How do TGA registration consulting and an Australian Sponsor differ?
- What responsibilities should Chinese manufacturers clarify before choosing an Australian Sponsor?
- Australia’s TGA UDI system: a compliance guide for medical device manufacturers
Official references
- TGA: The role of the sponsor
- TGA: Post-market responsibilities for medical devices
- TGA: Evidence requirements for medical device market authorisation
- TGA: Manufacturer evidence
- TGA: Reporting medical device adverse events
- TGA: Recalls, product alerts and product corrections
- TGA: Distribution records and retention periods
- TGA: Do not use “TGA approved” in advertising
- TGA: current application fees and annual charges
- TGA: changing the Sponsor of a therapeutic good
Sources checked: 2026-10-21. Assess each device and project against the applicable current requirements.
